Stan Smith is Director at MAIA Biotechnology, Inc. (MAIA). They have made 17 open-market trades across 1 company since 2022, most recently 2026-06-01.
CIK 0001913199
17 open-market purchases totalling $3.6M since 2022, never a sale. Across 17 scored buys the stock is up 10.5% at ninety days, and 8.6 points ahead of the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MAIA | 1,519,178 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-06-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 47% | 53% | 47% |
| Avg Move | +5.0% | +6.2% | +10.5% |
| Alpha | +4.8% | +7.0% | +8.6% |
| Scored | 17 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MAIA | BUY | 2026-06-01 | 2026-06-02 | $1.34 | $100K | -3.0% | +8.9% | -3.0% |
| MAIA | BUY | 2025-12-22 | 2025-12-23 | $1.22 | $140K | +8.5% | +70.2% | +5.0% |
| MAIA | BUY | 2025-12-05 | 2025-12-09 | $1.20 | $11K | -13.5% | +17.7% | +5.7% |
| MAIA | BUY | 2025-11-26 | 2025-12-01 | $1.04 | $16K | +34.4% | +25.4% | +69.7% |
| MAIA | BUY | 2025-11-24 | 2025-11-26 | $0.98 | $25K | +19.5% | +38.9% | +114.2% |
| MAIA | BUY | 2025-10-01 | 2025-10-02 | $1.30 | $25K | -19.2% | -36.3% | -15.9% |
| MAIA | BUY | 2025-06-03 | 2025-06-05 | $1.50 | $50K | -17.4% | -9.0% | -24.9% |
| MAIA | BUY | 2025-05-08 | 2025-05-12 | $1.50 | $100K | -6.3% | -8.4% | -22.0% |
| MAIA | BUY | 2025-03-03 | 2025-03-05 | $1.50 | $38K | +3.7% | -6.8% | +8.7% |
| MAIA | BUY | 2025-02-24 | 2025-03-05 | $1.50 | $75K | +3.7% | -6.8% | +8.7% |
| MAIA | BUY | 2024-12-13 | 2024-12-13 | $1.87 | $47K | -7.3% | +3.2% | -28.2% |
| MAIA | BUY | 2024-11-01 | 2024-11-04 | $2.51 | $502K | -27.8% | -31.9% | -35.9% |
| MAIA | BUY | 2024-04-25 | 2024-04-26 | $2.03 | $599K | -1.0% | +33.9% | +10.7% |
| MAIA | BUY | 2024-03-14 | 2024-03-15 | $1.17 | $400K | +63.2% | +34.2% | +149.3% |
| MAIA | BUY | 2023-04-27 | 2023-04-28 | $2.25 | $300K | +2.3% | -9.4% | -12.8% |
| MAIA | BUY | 2023-04-20 | 2023-04-21 | $3.74 | $37K | -17.6% | -24.7% | -29.0% |
| MAIA | BUY | 2023-03-24 | 2023-03-28 | $3.49 | $3K | +7.1% | -29.3% | -35.2% |
| MAIA | BUY | 2023-03-22 | 2023-03-24 | $3.32 | $11K | +0.0% | -19.3% | -35.0% |
| MAIA | BUY | 2023-03-20 | 2023-03-22 | $3.23 | $19K | +5.0% | -13.2% | -37.9% |
| MAIA | BUY | 2023-03-09 | 2023-03-13 | $4.03 | $14K | -23.3% | -8.0% | -38.3% |
| MAIA | BUY | 2023-03-07 | 2023-03-09 | $4.21 | $21K | -28.5% | -15.4% | -45.0% |
| MAIA | BUY | 2023-03-03 | 2023-03-07 | $4.40 | $31K | -24.6% | -20.7% | -46.0% |
| MAIA | BUY | 2023-03-01 | 2023-03-03 | $4.47 | $988 | -18.1% | -21.4% | -43.4% |
| MAIA | BUY | 2023-02-27 | 2023-03-01 | $4.48 | $8K | -14.9% | -22.3% | -46.1% |
| MAIA | BUY | 2023-02-21 | 2023-02-23 | $4.48 | $6K | -8.3% | -26.7% | -51.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.